Dailypharm Live Search Close

Janssen Korea voluntarily withdrew Tylenol 500mg

By Lee, Tak-Sun | translator Choi HeeYoung

21.12.09 12:06:38

°¡³ª´Ù¶ó 0
Effect of Hyangnam plant shutdown



It is known that the item license for Janssen Korea's antipyretic analgesic "Tylenol 500mg" will be withdrawn soon. This was expected to some extent because the Hyangnam plant will be shut down at the end of this year. Janssen has already been approved for imported items with the same ingredients and the same dosage. According to the MFDS on the 9th, Janssen Korea expressed its intention to withdraw "Tylenol 500mg," which was approved in Korea in 2001.

This product has been manufactured at Janssen Korea's domestic factory (Hyangnam). However, as Janssen announced that the Hyangnam plant will be shut down this year, related manufacturing items are also undergoing withdrawal procedures.

Ja

Lee, Tak-Sun(hooggasi2@dailypharm.com)
If you want to see the full article, please JOIN US (click)